In our due diligence, we always validate if there is a fit both with the innovation needs of our customers as well as the areas in which Philips has the ambition to further build a presence. This helps us to validate the opportunity to bring commercial opportunities to our businesses over the course of our investment period. Further, we look at the stand-alone value creation potential of the start-up, similar to what an institutional investor would do.
The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.